Metacognitive training for psychosis (MCT): past, present, and future.


Journal

European archives of psychiatry and clinical neuroscience
ISSN: 1433-8491
Titre abrégé: Eur Arch Psychiatry Clin Neurosci
Pays: Germany
ID NLM: 9103030

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 28 05 2021
accepted: 01 03 2022
medline: 5 6 2023
pubmed: 27 3 2022
entrez: 26 3 2022
Statut: ppublish

Résumé

This article provides an overview and retrospective on metacognitive training for psychosis (MCT), which first appeared approximately 2 decades ago. We recount how our empirical understanding of psychosis at that time led to the first preliminary version of the program. We describe setbacks and challenges that led to major changes, including revisions to existing modules (e.g., more focus on metacognitive variables, particularly on decision confidence as one of the primary targets of treatment) and the creation of new modules addressing mood, as well as attempts to improve sustainability of effects via homework exercises and a smartphone app ( www.uke.de/mct_app ). We have also enhanced dissemination efforts by creating new culturally sensitive language versions and facilitating low-threshold training through e-learning courses ( www.uke.de/e-mct ). Finally, we discuss several meta-analyses on the efficacy of MCT that have been published over the last decade. While reviews were initially inconsistent, possibly reflecting the insufficient statistical power and lower design quality of the first MCT studies, more recent meta-analyses have confirmed the efficacy of MCT on positive symptoms, insight, and cognitive biases, which has led to the inclusion of MCT in some national treatment guidelines for schizophrenia.

Identifiants

pubmed: 35338378
doi: 10.1007/s00406-022-01394-9
pii: 10.1007/s00406-022-01394-9
pmc: PMC8956140
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

811-817

Informations de copyright

© 2022. The Author(s).

Références

Psychiatry Res. 2018 Nov;269:753-762
pubmed: 30273901
BMC Psychiatry. 2021 Jan 13;21(1):38
pubmed: 33441093
Dialogues Clin Neurosci. 2019 Sep;21(3):309-317
pubmed: 31749655
Clin Psychol Psychother. 2019 Mar;26(2):227-240
pubmed: 30456821
Schizophr Res. 2020 Jan;215:399-407
pubmed: 31471248
Behav Res Ther. 2006 Aug;44(8):1147-58
pubmed: 16226221
Worldviews Evid Based Nurs. 2018 Apr;15(2):130-139
pubmed: 29489070
Br J Clin Psychol. 1999 Jun;38(2):113-54
pubmed: 10389596
Psychol Med. 2011 Sep;41(9):1823-32
pubmed: 21275083
Clin Psychol Rev. 2021 Jun;86:102007
pubmed: 33864968
J Behav Ther Exp Psychiatry. 2017 Sep;56:113-121
pubmed: 27817827
Cogn Neuropsychiatry. 2014;19(6):471-84
pubmed: 24749790
Q J Exp Psychol A. 1988 Nov;40(4):801-12
pubmed: 3212213
J Behav Ther Exp Psychiatry. 2018 Jun;59:161
pubmed: 29279140
Schizophr Res. 2016 Dec;178(1-3):74-79
pubmed: 27591821
Psychol Med. 2014 Oct;44(14):3025-35
pubmed: 25066223
Shanghai Arch Psychiatry. 2015 Jun 25;27(3):149-57
pubmed: 26300597
Br J Psychiatry. 2013 Nov;203(5):327-33
pubmed: 24187067
J Clin Exp Neuropsychol. 2006 May;28(4):605-17
pubmed: 16624787
Psychol Med. 2016 Jul;46(9):2003-5
pubmed: 26888290
Psychiatry Res. 2006 Jun 15;142(2-3):157-65
pubmed: 16631258
Curr Biol. 2011 Dec 6;21(23):R941-5
pubmed: 22153158
Front Psychol. 2015 Oct 06;6:1450
pubmed: 26500570
Schizophr Res. 2018 Nov;201:20-26
pubmed: 29903626
J Psychiatr Pract. 2012 Sep;18(5):321-8
pubmed: 22995959
Schizophr Bull. 2019 Jan 1;45(1):27-36
pubmed: 30376124
JMIR Mhealth Uhealth. 2021 Jul 12;9(7):e26498
pubmed: 34255711
Rev Colomb Psiquiatr (Engl Ed). 2021 Mar 18;:
pubmed: 33734989
Clin Psychol Rev. 2020 Jun;78:101854
pubmed: 32361339
JAMA Psychiatry. 2022 May 1;79(5):417-429
pubmed: 35320347
Eur Arch Psychiatry Clin Neurosci. 2017 Jun;267(4):335-339
pubmed: 27194554
Schizophr Bull. 2014 May;40(3):558-65
pubmed: 23661634
Psychol Rev. 1996 Jul;103(3):582-91; discusion 592-6
pubmed: 8759048
Psychol Med. 2020 Oct;50(14):2289-2301
pubmed: 33050956
Schizophr Bull. 2016 Jul;42(4):952-62
pubmed: 26748396
Aust N Z J Psychiatry. 2014 Dec;48(12):1126-36
pubmed: 24159051
Schizophr Res Cogn. 2021 Dec 06;28:100230
pubmed: 35242604
Psychol Med. 1987 Feb;17(1):49-57
pubmed: 3575577
J Nerv Ment Dis. 2002 Sep;190(9):641-3
pubmed: 12357100

Auteurs

Steffen Moritz (S)

Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. moritz@uke.uni-hamburg.de.

Mahesh Menon (M)

Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.
BC Psychosis Program, Vancouver Coastal Health, Vancouver, BC, Canada.

Ryan Balzan (R)

College of Education, Psychology and Social Work, Flinders University, Bedford Park, SA, Australia.
Orama Institute, Flinders University, Bedford Park, SA, Australia.

Todd S Woodward (TS)

Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.
Mental Health and Addictions Research Institute, Vancouver, BC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH